The Food and Drug Administration formally authorized booster shots for people over the age of 65 as well as people who are at high risk of severe illness. Now advisors to the Centers for Disease Control and Prevention must decide who qualifies as high-risk. (The New York Times)

Delta Air Lines reported that 82% of its employees have been vaccinated. The company announced last month that workers would have to pay $200 more per month for insurance if they did not receive the shot. (Reuters)

Catalent has closed a deal with Phathom Pharmaceuticals to manufacture its lead drug, vonoprazan. The drug aims to treat gastrointestinal diseases. (Endpoints News)

About 10% of the American population remains “unvaccinated but willing,” according to a Department of Health and Human Services report. Within that group, many people lack transportation or access to vaccination. (The Washington Post)

More white academics are flocking to health equity work, raising concerns that some are “health equity tourists” taking away from researchers of color. Critics pointed out that the Journal of the American Medical Association does not consider author demographics in the research papers it selects. (STAT)